美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

First Trust Health Care AlphaDEX Fund

131.02

+1.361.05%

成交量：4.92萬

成交額：644.89萬

市值：11.40億

市盈率：- -

高：131.26

開：131.16

低：130.55

收：129.66

52周最高：135.82

52周最低：104.53

股本：870.00萬

流通股本：870.00萬

量比：1.06

換手率：0.57%

股息：1.02

股息率：0.78%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Humana同意在美國的藥品訴訟中不提及Teva與以色列的關聯

美國總統特朗普：醫療補助將不再為未成年人提供性別轉換手術和激素治療的資金。

板塊普漲之際十隻量化評分強勁的大盤醫療保健股

哈門那旗下健康視野計劃攜手健康流科技，共築印第安納州家庭護理人才高地

30周狂賣500萬張！GLP-1引爆行情，減肥藥口服時代來臨

小摩上調哈門那目標價至393美元

Hims & Hers Health次季虧損超預期，轉向品牌減肥藥導致成本上升

GLP-1為王、專利懸崖逼近、新賽道搶跑跨國藥企2026上半年業績背後的版圖重組

每日经济新闻

GLP-1為王、專利懸崖逼近、新賽道搶跑：跨國藥企2026上半年業績背後的版圖重組

每日经济新闻

特瓦公司試圖向陪審團隱瞞與以色列的關聯，並援引加沙戰爭作為理由

美國銀行每年砸2.5億美元支持員工使用GLP-1減肥藥

安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發

环球市场播报

阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大

重塑全球藥企版圖！阿斯利康擬洽購百時美施貴寶，或締造史上最大醫藥併購案

重塑全球藥企版圖！阿斯利康(AZN.US)擬洽購百時美施貴寶(BMY.US)，或締造史上最大醫藥併購案

美國醫療保險和醫療補助服務中心：擴大版關節置換綜合護理模式自2028年1月1日起強制實施。

瑞銀上調哈門那目標價至405美元

Leerink Partners 上調哈門那評級：從「與大盤持平」升至「跑贏大盤」，目標價大幅上調至513美元

個股動態匯總：福特、卡特彼勒、梯瓦製藥、星巴克

美國醫療保險和醫療補助服務中心：已確定2027財年專業護理機構預期支付系統費率調整方案，調整後，面向專業護理機構的總支付

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/FXH/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","market":"US","secType":"STK","nameCN":"First Trust Health Care AlphaDEX Fund","latestPrice":131.015,"timestamp":1789405932737,"preClose":129.66,"halted":0,"volume":49230,"delay":0,"changeRate":0.010450408761375828,"floatShares":8700002,"shares":8700002,"eps":0,"marketStatus":"交易中","change":1.355,"latestTime":"09-14 13:17:17 EDT","open":131.16,"high":131.26,"low":130.551,"amount":6448852.8351,"amplitude":0.005468,"askPrice":131.03,"askSize":364,"bidPrice":130.97,"bidSize":182,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":129.66,"sharesOutstanding":7900002,"nav":129.34,"aum":1125258258.68,"dividendRate":0.007818,"bidAskSpread":0.00058,"postHourTrading":{"tag":"盘后","latestPrice":129.66,"preClose":129.66,"latestTime":"19:30 EDT","volume":30,"amount":3886.87,"timestamp":1789169406838,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.060797,"impliedVol":0.1358,"impliedVolPercentile":0.3546},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","floatShares":8700002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.060797,"shares":8700002,"dividePrice":1.0243,"high":131.26,"amplitude":0.005468,"preClose":129.66,"low":130.551,"week52Low":104.525,"pbRate":"--","week52High":135.8199,"institutionHeld":0,"latestPrice":131.015,"committee":-0.333333,"eps":0,"divideRate":0.007818,"volume":49230,"delay":0,"ttmEps":0,"open":131.16,"prevYearClose":113.8213,"prevWeekClose":129.66,"prevMonthClose":132.89,"prevQuarterClose":122.4,"fiveDayClose":133.456,"twentyDayClose":131.22,"sixtyDayClose":115.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FXH","amount":0.1183,"announcedDate":"2026-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FXH","amount":0.1858,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FXH","amount":0.1399,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FXH","amount":0.5821,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FXH","amount":0.0616,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FXH\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-23","recordDate":"2022-09-26","paymentDate":"2022-09-30","value":0.1007,"currency":"USD"},{"executeDate":"2022-12-23","recordDate":"2022-12-27","paymentDate":"2022-12-30","value":0.1214,"currency":"USD"},{"executeDate":"2023-03-24","recordDate":"2023-03-27","paymentDate":"2023-03-31","value":0.0438,"currency":"USD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-06-30","value":0.0377,"currency":"USD"},{"executeDate":"2023-09-22","recordDate":"2023-09-25","paymentDate":"2023-09-29","value":0.0332,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FXH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659112168","title":"Humana同意在美國的藥品訴訟中不提及Teva與以色列的關聯","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112168","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659112168?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 22:18","pubTimestamp":1786630699,"startTime":"0","endTime":"0","summary":"Humana和特瓦尚未立即回应置评请求。Humana在周三提交的文件中表示，其律师在庭审期间“在辩论或质询中不会提及特瓦是一家以色列公司这一事实”。特瓦否认了Humana的指控，即该公司与其他制药商串通，人为抬高某些药物的价格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4S44A17Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","LU0390134368.USD","IHF","LU0208291251.USD","SG9999014021.USD","LU0348723411.USD","LU1093756168.USD","LU0170899867.USD","LU0266013472.USD","BK4588","BK4566","LU1983260115.SGD","LU0211331839.USD","BK4154","LU0238689110.USD","LU0070302665.USD","SG9999014005.SGD","SG9999014013.SGD","FXH","HUM","LU0256863811.USD","LU0417517546.SGD","BK4533","LU1093756325.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658469849","title":"美國總統特朗普：醫療補助將不再為未成年人提供性別轉換手術和激素治療的資金。","url":"https://stock-news.laohu8.com/highlight/detail?id=2658469849","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658469849?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 05:23","pubTimestamp":1786483407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0390134368.USD","LU0211331839.USD","RSPH","SG9999014013.SGD","LU0348723411.USD","LU0208291251.USD","LU0320765489.SGD","LU1983260115.SGD","BK4533","LU0256863811.USD","LU0070302665.USD","LU0417517546.SGD","SG9999014005.SGD","LU0170899867.USD","BK4588","LU1093756325.SGD","LU1093756168.USD","FXH","SG9999014021.USD","LU0238689110.USD","IHF","HUM","LU0266013472.USD","BK4566","BK4585","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911935","title":"板塊普漲之際 十隻量化評分強勁的大盤醫療保健股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911935","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911935?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:27","pubTimestamp":1786462073,"startTime":"0","endTime":"0","summary":"经历 2022-2023年板块低迷后，医疗保健板块在2026年重新积聚上涨动能。Centene Corporation以4.97分接近满分的量化评分位居榜单首位；Corcept Therapeutics、Bright Spring Health Services紧随其后，评分分别为4.93、4.91；Halozyme Therapeutics、Humana跻身前五，均获强烈“买入”评级。即便板块整体处在历史高位，个股之间量化评分分化依旧显著。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303689","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHIP","IE0004445239.USD","IE00B1XK9C88.USD","SG9999014880.SGD","IE000M9KFDE8.USD","IE00B19Z9P08.USD","LU1778281490.HKD","SG9999014906.USD","IE00B2B36J28.USD","LU1201861165.SGD","BK4581","LU0143551892.USD","LU2244417387.USD","LU0965509283.SGD","SG9999014914.USD","LU0882574055.USD","LU0432979614.USD","LU0980610538.SGD","FHLC","IE00B775H168.HKD","LU2461242641.AUD","LU2089283258.USD","EKG","LU1674673428.USD","LU0823416689.USD","IE0004445015.USD","LU1732800096.USD","PTH","UNH","LU0708994859.HKD","SG9999017495.SGD","LU1506573853.SGD","LU0198837287.USD","LU2552382058.USD","LU2361044865.SGD","LU0965509101.SGD","LU1074936037.SGD","LU0566484027.USD","IE00B7SZLL34.SGD","LU0251132253.USD","LU0072461881.USD","LU2954938101.SGD","BK4154","IE00B894F039.SGD","LU0320765489.SGD","BK4007","LU0353189763.USD","BK4613","IE0002141913.USD","LU0316494557.USD","LU1291159041.SGD","LU0128525929.USD","LU0353189680.USD","LU0158827781.USD","SG9999018865.SGD","LU0154245673.USD","LU2491050154.USD","LU0238689110.USD","LU0149725797.USD","LU1791710582.SGD","LU2111349929.HKD","LU2357305700.SGD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","IE00BKPKM429.USD","LU0820561818.USD","LU0943347566.SGD","LU2999663052.SGD","SGXZ81514606.USD","LU0048584097.USD","LU2552382132.HKD","LU1670627923.USD","LU0187121727.USD","LU2125154778.USD","SOLV","BK4534","SG9999014005.SGD","IXJ","IE00BZ1G4Q59.USD","LU2491050071.SGD","LU0052756011.USD","LU1066051225.USD","LU0345770993.USD","LU2279689827.SGD","LU1061106388.HKD","LU1119994496.HKD","LU1559883803.SGD","LU2362540622.SGD","BK4559","LU1548497426.USD","BK4196","LU0456855351.SGD","LU0949170772.SGD","LU1989764664.SGD","LU2065170008.USD","IE00B19Z9505.USD","IE00B7KXQ091.USD","LU0320765059.SGD","LU0965508806.USD","LU1093756325.SGD","LU0203347892.USD","BK4585","LU0320765992.SGD","LU0683600562.USD","IE0002270589.USD","LU0787776722.HKD","LU2324357040.USD","CORT","LU2087625088.SGD","BK4167","LU2361044949.HKD","IE00BFSS8Q28.SGD","LU2236285917.USD","LU0208291251.USD","LU0496365809.HKD","LU0058720904.USD","LU2125154935.USD","LU2112291526.USD","IE00B19Z9Z06.USD","LU1066051811.HKD","LU2468319806.SGD","LU0859254822.USD","IE00B4JS1V06.HKD","LU1323610961.USD","VHT","LU0079474960.USD","LU0256863811.USD","LGHT","LU0203345920.USD","BK4588","DVA","NBIX","SG9999002224.SGD","LU0545039389.USD","LU2211815571.USD","LU0053666078.USD","LU0130517989.USD","LU0122379950.USD","IE00BJJMRX11.SGD","LU2065171402.SGD","SG9999001176.USD","LU0661504455.SGD","SG9999018857.SGD","IE00BFXG1179.USD","LU2271345857.HKD","LU0158827948.USD","LU0170899867.USD","IE00B4R5TH58.HKD","LU2357627491.SGD","IE00BFSS7M15.SGD","LU1934455863.HKD","LU0965509010.AUD","LU0912757837.SGD","LU2242649171.HKD","BK4533","LU0130102774.USD","IE0005OL40V9.USD","IE00BZ9MQY76.HKD","LU0154245756.USD","LU0553294199.USD","LU0354030511.USD","LU0708995401.HKD","IE00BKVL7J92.USD","IE00BJJMRY28.SGD","LU1814569148.SGD","LU0289739699.SGD","LU1037948897.HKD","LU1674673691.USD","VEEV","LU0348723411.USD","BK4139","HALO","LU0861579265.USD","LU2552382215.SGD","LU1854104046.USD","LU2023251221.USD","LU1854103824.USD","LU0130518102.USD","TRUH","BK4532","LU1267930490.SGD","LU1914381329.SGD","LU1496350502.SGD","SGXZ31699556.SGD","LU0077335932.USD","LU0211326755.USD","LU2065169927.USD","SGXZ99366536.SGD","IE00B19Z8X17.USD","FXH","LU1988902786.USD","LU1934455194.USD","LU0795875169.SGD","SG9999001176.SGD","LU0795875086.SGD","SG9999014013.SGD","LU1791710400.SGD","LU0094547139.USD","PSCH","LU1064131342.USD","LU0345770308.USD","LU0310800379.SGD","LU2028103732.USD","LU1720051108.HKD","LU1699723380.USD","LU0128525689.USD","LU1066051498.USD","LU2462591277.SGD","LU1093756168.USD","LU0109394709.USD","BTSG","LU0211328371.USD","LU1732799900.SGD","LU2089984988.USD","LU0342679015.USD","UNHG","LU2133065610.SGD","SGXZ57979304.SGD","FBT","LU0477156953.USD","LU1267930730.SGD","LU1057294990.SGD","LU2360032135.SGD","LU1003077747.HKD","LU1066053197.SGD","SG9999002232.USD","LU0390134368.USD","CNCG","LU1989764748.USD","SG9999014021.USD","LU0029864427.USD","JDOC","IHF","IE00BWXC8680.SGD","BK4566","LU1670628061.USD","LU0689472784.USD","LU1201861249.SGD","SG9999014898.SGD","LU0310799852.SGD","LU1153585028.USD","LU0738911758.USD","LU0266013472.USD","LU0130103400.USD","LU0648001328.SGD","IYH","FFOX","SGXZ51526630.SGD","LU0234572021.USD","IE00B3T34201.USD","LU2362541273.HKD","LU2491049909.HKD","LU1934455277.USD","LU2089284900.SGD","LU1267930227.SGD","LU1718418525.SGD","LU2264538146.SGD","LU1720051017.SGD","LU1983260115.SGD","CNC","LU0354030438.USD","IE0009355771.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU0070302665.USD","HRTS","LU0114720955.EUR","SG9999013999.USD","HUM","BK4528","LU2347655156.SGD","LU0310800965.SGD","LU0557290698.USD","LU0820562030.AUD","LU0889565916.HKD","BK4504","RXL","IE0034235188.USD","LU2361045086.USD","LU0648000940.SGD","LU0162691827.USD","LU1037948541.HKD","LU0011850046.USD","IE00B19Z3581.USD","LU0107464264.USD","LU0211327993.USD","LU0672654240.SGD","IE00B19Z8W00.USD","LU2362541513.USD","LU0477156797.USD","LU2065171311.SGD","LU1989771016.USD","LU1023059063.AUD","LU0976567544.SGD","IE00BN29S564.USD","LU0528227936.USD","LU0417517546.SGD","LU1261432733.SGD","LU0211326839.USD","LU1551013342.USD","GDOC","LU0097036916.USD","BK4198","LU1069347547.HKD","LU0820561909.HKD","UNHW","LU0211331839.USD","LU1551013425.SGD","LU0053671581.USD","LU0109391861.USD","LU1267930573.SGD","LU1035773651.USD","LU1084165304.USD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","XLV","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178334778","title":"哈門那旗下健康視野計劃攜手健康流科技，共築印第安納州家庭護理人才高地","url":"https://stock-news.laohu8.com/highlight/detail?id=1178334778","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178334778?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 20:02","pubTimestamp":1786449722,"startTime":"0","endTime":"0","summary":"哈门那（Humana）在印第安纳州推出的“健康视野”（Healthy Horizons）计划，正与健康流科技（HealthStream）展开深度合作。此次携手，旨在扩充并夯实家庭护理领域的人才队伍。这项举措，恰似一场及时雨，为当地护理行业注入新的活力。通过整合双方资源，它们致力于吸引更多专业人才投身于家庭护理工作，并进一步提升现有从业者的技能水平。此举不仅关乎个人职业发展，更将对整个社区的健康服务体系产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","BK4566","HSTM","LU0390134368.USD","IHF","LU1093756325.SGD","LU0256863811.USD","BK4588","SG9999014021.USD","FXH","LU0417517546.SGD","LU0320765489.SGD","LU0238689110.USD","BK4167","SG9999014005.SGD","LU1983260115.SGD","BK4533","BK4585","LU0208291251.USD","LU0266013472.USD","LU0070302665.USD","HUM","SG9999014013.SGD","LU1093756168.USD","LU0211331839.USD","LU0348723411.USD","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996687","title":"30周狂賣500萬張！GLP-1引爆行情，減肥藥口服時代來臨","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996687","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658996687?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 17:20","pubTimestamp":1786440001,"startTime":"0","endTime":"0","summary":"据开源证券研报，Wegovy口服片剂上市后处方量快速攀升，30周累计突破500万张，有效扩宽了GLP-1药物可及性边界，驱动减重产业链持续高景气。2026年被业内视作GLP-1减肥药的“口服元年”。产业链全面受益随着海外商业化落地持续超预期，全球GLP-1减重市场规模迎来指数级增长。口服GLP-1药物放量带动规模化生产需求激增，海外药企产能逐步承压，持续将生产环节外包至国内优质代工企业。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/11/20260811783677.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260811/32331742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["CURE","BK4590","PJP","RSPH","THNR","BK4144","PINK","MEDI","NBDS","XLVI","IYH","TRUH","FXH","JDOC","NVOC","GLP","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658696761","title":"小摩上調哈門那目標價至393美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658696761","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658696761?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 14:46","pubTimestamp":1786430776,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0170899867.USD","LU0348723411.USD","BK4154","LU1983260115.SGD","LU0238689110.USD","LU1093756325.SGD","BK4533","HUM","LU0390134368.USD","LU0211331839.USD","UUP","LU0070302665.USD","LU0266013472.USD","SG9999014005.SGD","BK4566","LU0208291251.USD","BK4588","UDN","LU0417517546.SGD","FXH","BK4585","LU1093756168.USD","LU0256863811.USD","SG9999014021.USD","IHF","LU0320765489.SGD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969925","title":"Hims & Hers Health次季虧損超預期，轉向品牌減肥藥導致成本上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969925","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969925?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:46","pubTimestamp":1786419965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MEDI","IYH","XLVI","THNR","PJP","FHLC","RSPH","FXH","PINK","CURE","NBDS","NVOC","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658535936","title":"GLP-1為王、專利懸崖逼近、新賽道搶跑 跨國藥企2026上半年業績背後的版圖重組","url":"https://stock-news.laohu8.com/highlight/detail?id=2658535936","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658535936?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363243,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608103836820982.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608103836820982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PJP","FXH","PPH","RSPH","BK4144","GLP","FHLC","BME","GSKH","TRUH","MEDI","JDOC","BBH","APXH","IHE","BK4590","TMED","BBP","PBPH","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641919","title":"GLP-1為王、專利懸崖逼近、新賽道搶跑：跨國藥企2026上半年業績背後的版圖重組","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641919","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641919?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 21:49","pubTimestamp":1786110543,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608073835488463.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608073835488463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4590","RSPH","FXH","IHE","BBP","GLP","TRUH","MEDI","IYH","PBPH","BK4144","GSKH","TMED","FHLC","JDOC","APXH","PPH","BME","PJP","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657655274","title":"特瓦公司試圖向陪審團隱瞞與以色列的關聯，並援引加沙戰爭作為理由","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655274","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657655274?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 00:19","pubTimestamp":1786033193,"startTime":"0","endTime":"0","summary":"特瓦公司试图向陪审团隐瞒与以色列的关联，并援引加沙战争作为理由特瓦指出，自加沙战争以来，对以色列的敌意日益加剧这家制药公司表示，公司起源与本案无关关于定价指控的庭审定于下月举行Mike Scarcella路透华盛顿8月6日-特瓦制药公司已请求美国法官禁止保险公司胡玛纳在一场重大的药品价格垄断审判中向陪审团透露其是一家以色列公司，理由是公众对加沙战争  的强烈看法可能会影响审判程序，并影响该公司获得公正审理的能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL4S44321U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983260115.SGD","LU0320765489.SGD","LU0170899867.USD","LU0070302665.USD","BK4007","IHF","BK4566","FXH","BK4154","HUM","LU0238689110.USD","SG9999014005.SGD","LU0211331839.USD","BK4596","SG9999014021.USD","LU0266013472.USD","LU0208291251.USD","BK4559","LU0348723411.USD","BK4585","LU2324357040.USD","LU1093756168.USD","LU0256863811.USD","LU1093756325.SGD","LU0390134368.USD","TEVA","SG9999014013.SGD","BK4584","LU0417517546.SGD","BK4557","BK4588","BK4533","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657896386","title":"美國銀行每年砸2.5億美元支持員工使用GLP-1減肥藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2657896386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657896386?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 17:06","pubTimestamp":1786007162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["THNR","LU0053666078.USD","LLYX","UYG","IE00B19Z3B42.SGD","BK4590","LU0211331839.USD","BAC","FTXO","LU0314106906.USD","GLP","IE0001KFT4U8.USD","KBWB","LU1506573853.SGD","BK4534","IE00BZ1G4Q59.USD","ELIS","FXH","LU0980610538.SGD","LLII","LLYZ","PJP","MEDI","IYF","LU0170899867.USD","RSPH","TFNS","JDOC","OZEM","LU0130103400.USD","XLVI","FHLC","VFH","NBDS","XLF","IYG","PGF","CURE","IYH","TRUH","LU1496350171.SGD","BK4588","ELIL","FNCL","LU0106831901.USD","IE00BBT3K403.USD","LU0648001328.SGD","PINK","LU1280957306.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657674945","title":"安進二季度強勁藥品銷售，上調預期，將終止早期減肥藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2657674945","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657674945?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 05:11","pubTimestamp":1785877860,"startTime":"0","endTime":"0","summary":"　　$安进$公司于周二美股收盘后公布财报，第二季度强劲药品销售提振公司利润，因此上调了全年预期，但同时表示将终止一款早期减肥疗法的开发。　　这家生物技术公司周二表示，将停止AMG 513的开发，这是一款目前处于1期研究阶段的潜在减肥疗法。安进称，该研究将完成以跟踪已入组受试者。　　随着AMG 513开发的终止，安进在该领域唯一的候选药物是MariTide，该药目前正在进行针对肥胖、2型糖尿病和慢性体重管理等适应症的3期研究。","market":"fut","thumbnail":"https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e910a0d7e1da6d4a41f6d581ee31760f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimezkz1673958.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4566","LU0320765992.SGD","IE00BJT1NW94.SGD","NBDS","PINK","IE00BFTCPJ56.SGD","BK4534","RSPH","NVOC","IBBQ","LU0109394709.USD","LU0058720904.USD","PBE","LU0889565916.HKD","LU0122379950.USD","LU2089984988.USD","BBH","LU0289739699.SGD","BK4581","IE0009355771.USD","LU1983299246.USD","IBB","LU1061106388.HKD","BK4139","TRUH","CURE","IE00B4R5TH58.HKD","MEDI","PJP","LU1571399168.USD","LU2242646821.SGD","THNR","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU2468319806.SGD","FXH","IYH","LU0868494617.USD","BK4533","IE00B2B36J28.USD","BK4588","LU2242652126.USD","SG9999001440.SGD","BK4599","TBXU","IE0002141913.USD","FHLC","XLVI","AMGN","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656080539","title":"阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656080539","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656080539?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:26","pubTimestamp":1785835565,"startTime":"0","endTime":"0","summary":"蓝鲸新闻记者联系了阿斯利康方面，对方拒绝对此置评。此外，BMS有神经管线与Eliquis后续心血管资产，可补足AZ在相关领域的短板。据BMO资本在研报中指出，两家公司都没有足够的财务实力直接收购对方，预计阿斯利康能掏出约370亿美元，而百时美施贵宝约为320亿美元，远低于搞定一桩价值4000亿美元合并所需的资金。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785835141389493693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["AZN","AZNH","LU1032466523.USD","LU0868494617.USD","LU2596442595.SGD","LU0432979614.USD","BMY","PJP","LU1585245621.USD","RSPH","JDOC","PBPH","LU1670711123.USD","LU0225284248.USD","APXH","LU0321505868.SGD","IHE","LU0985481810.HKD","TRUH","FTXH","AZ","LU0882574055.USD","PPH","LU0267386448.USD","LU1868837300.USD","LU1093756168.USD","LU2089984988.USD","BK4588","LU0128525929.USD","TMED","LU2462157665.USD","LU1868836591.USD","IYH","LU2237443382.USD","BK4559","LU0321505439.SGD","BBP","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1868836914.USD","BBH","MEDI","FHLC","LU1670710588.SGD","LU2237443895.HKD","GSKH","LU2242646821.SGD","LU1093756325.SGD","FXH","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656346866","title":"重塑全球藥企版圖！阿斯利康擬洽購百時美施貴寶，或締造史上最大醫藥併購案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656346866","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656346866?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 07:30","pubTimestamp":1785713456,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据知情人士透露，阿斯利康已就收购百时美施贵宝展开探讨，这桩超级交易若达成，将缔造全球规模最大的制药企业之一。阿斯利康市值超过百时美施贵宝百时美施贵宝正为其部分最核心产品面临专利保护到期做准备，包括抗凝药艾乐妥与抗癌药欧狄沃。两款产品合计约占百时美施贵宝销售额的一半。上周，百时美施贵宝公布季度销售额 130 亿美元，创历史最高。阿斯利康目前是伦敦证券交易所市值第二大的公司。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"重塑全球药企版图！阿斯利康拟洽购百时美施贵宝，或缔造史上最大医药并购案","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2473716301.USD","BMY","LU0096364046.USD","IE00BJT1NW94.SGD","LU1032466523.USD","LU2456880835.USD","XBIX","IE0009355771.USD","LU0432979614.USD","PPH","LU1291159041.SGD","CURE","LU1323610961.USD","BK4581","FHLC","PILL","LU1718418525.SGD","LU2360032135.SGD","IE00BSNM7G36.USD","FTXH","IE00BFTCPJ56.SGD","BK4534","LU1585245621.USD","FXH","LU0061475181.USD","BK4559","IEHS","LU1992135472.HKD","LU2237443382.USD","LU2242652126.USD","IHE","LU2237443549.SGD","LU2272731600.USD","SYNB","AZN","MEDI","RXL","JHMH","LU0029864427.USD","IE00B3T34201.USD","XPH","LU2237443978.SGD","RXD","IE00B5TLWC47.USD","LU2237443465.HKD","AZNH","LU2237443622.USD","LU1093756325.SGD","LU0456855351.SGD","LU2125154778.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656468693","title":"重塑全球藥企版圖！阿斯利康(AZN.US)擬洽購百時美施貴寶(BMY.US)，或締造史上最大醫藥併購案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656468693","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656468693?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 07:25","pubTimestamp":1785713101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","LU0306807586.USD","IHE","FXH","LU0058720904.USD","LU0456855351.SGD","RXD","LU2272731782.SGD","LU2089984988.USD","RXL","IE00B5TLWC47.USD","IE00BSNM7G36.USD","LU1267930573.SGD","XBIX","IE0002141913.USD","CURE","LU1868837136.USD","LU2596442595.SGD","LU1670710661.SGD","LU0985481810.HKD","IEHS","AZN","LU2125154935.USD","MEDI","IE00BJJMRZ35.SGD","AZNH","SYNB","IE00BFXG1179.USD","LU1032466523.USD","BK4581","LU1670711123.USD","LU0237698245.USD","IE00B3T34201.USD","FTXH","LU1074936037.SGD","LU2456880835.USD","XPH","BMY","BK4534","LU0225771236.USD","PILL","LU1989771016.USD","BK4588","IE0009355771.USD","LU0096364046.USD","FHLC","LU0029864427.USD","JHMH","LU1868836914.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656439976","title":"美國醫療保險和醫療補助服務中心：擴大版關節置換綜合護理模式自2028年1月1日起強制實施。","url":"https://stock-news.laohu8.com/highlight/detail?id=2656439976","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656439976?lang=zh_tw&edition=fundamental","pubTime":"2026-08-01 04:26","pubTimestamp":1785529584,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HUM","BK4566","RSPH","SG9999014005.SGD","IHF","FXH","LU1983260115.SGD","BK4585","LU0390134368.USD","LU0348723411.USD","LU0238689110.USD","BK4533","BK4154","LU0208291251.USD","SG9999014013.SGD","BK4588","LU0070302665.USD","LU0256863811.USD","LU0266013472.USD","LU0320765489.SGD","IEHS","UNHU","LU1093756168.USD","LU0417517546.SGD","LU1093756325.SGD","SG9999014021.USD","LU0170899867.USD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655548473","title":"瑞銀上調哈門那目標價至405美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2655548473","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655548473?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 17:31","pubTimestamp":1785490289,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["UDN","LU1983260115.SGD","LU1093756168.USD","LU1093756325.SGD","FXH","BK4585","LU0390134368.USD","LU0266013472.USD","SG9999014005.SGD","SG9999014021.USD","BK4533","LU0211331839.USD","SG9999014013.SGD","LU0238689110.USD","LU0070302665.USD","HUM","IHF","BK4566","LU0170899867.USD","BK4154","LU0256863811.USD","LU0208291251.USD","LU0348723411.USD","UUP","BK4588","LU0417517546.SGD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126084274","title":"Leerink Partners 上調哈門那評級：從「與大盤持平」升至「跑贏大盤」，目標價大幅上調至513美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126084274","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126084274?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 18:26","pubTimestamp":1785407171,"startTime":"0","endTime":"0","summary":"Leerink Partners 调整了对哈门那（Humana）的评级。该机构将其从“与大盘持平”提升至“跑赢大盘”。与此同时，目标价也被大幅上调，从原先的255美元直接翻倍，跃升至513美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4566","LU0266013472.USD","LU1983260115.SGD","SG9999014021.USD","BK4533","BK4585","BK4154","LU0348723411.USD","LU0238689110.USD","LU0390134368.USD","LU0170899867.USD","LU0070302665.USD","LU0417517546.SGD","LU0256863811.USD","LU1093756168.USD","BK4588","LU0320765489.SGD","SG9999014013.SGD","HUM","FXH","IHF","LU0208291251.USD","LU0211331839.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145089165","title":"個股動態匯總：福特、卡特彼勒、梯瓦製藥、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=1145089165","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145089165?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 06:45","pubTimestamp":1785365155,"startTime":"0","endTime":"0","summary":"其股价收盘微涨，幅度超过2%。卡特彼勒：该建筑设备制造商的股价却大跌约7%，原因在于市场对数据中心业务感到忧虑，加之贝尔德的分析师下调了其评级。其股价随之大涨，接近10%。公司股价下跌了6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA","BK4574","LU2543165471.USD","DECU","LU2168564065.EUR","SG9999014005.SGD","BK4209","BK4532","HWAY","SG9999014021.USD","LU0390134368.USD","PMDE","BK4585","HUM","LU1974910355.USD","CAT","LU1119993845.HKD","LU0877626530.USD","GXDW","LU1548497426.USD","SG9999000327.SGD","IE0008369823.USD","LU0149534421.HKD","LU2168564149.EUR","F","UXI","LU0348723411.USD","BK4154","VGFPF","GASZ","LU0868494708.USD","LU0164880469.USD","LU0070302665.USD","02888","BK4557","BK4596","BK4007","LU0205439572.USD","LU0823411888.USD","BK4504","LU2168564222.USD","SBUX","LU1093756168.USD","LU2023250504.SGD","IHF","LU2324357040.USD","BK1231","FEBU","LU0170899867.USD","LU0238689110.USD","BK4597","BK4610","BK4520","LU0868494617.USD","LU2264538146.SGD","BK4535","BK4533","BK4584","IE00BD6J9T35.USD","03143","BK4559","LU1481107354.HKD","MADE","LU0256863811.USD","RGLO","LU1917777945.USD","LU0417517546.SGD","FXH","LU0251142724.SGD","IE00BSNM7G36.USD","STAN.UK","BK4566","SG9999014013.SGD","LU0942090050.USD","BK1572","DB","BREW","LU2357305700.SGD","LU0211977185.USD","LU0266013472.USD","LU1720051017.SGD","SBU","LU1093756325.SGD","BK4588","FRDD","LU0211331839.USD","BK4099","LU2106854487.HKD","LU2237438978.USD","BK1601","LU1983299246.USD","VOTE","LU0882574139.USD","SG9999001689.USD","LU0320765489.SGD","BK4516","LU1720051108.HKD","LU1983260115.SGD","JOYT","LU0251131958.USD","IE00B3T34201.USD","TRUI","BK4552","LU0048573561.USD","BK4149","BK1619","LU0607220059.USD","RSHO","BK4118","LU1064131342.USD","LU2168564495.EUR","LU0208291251.USD","BK4555","LU1988902786.USD","LU2168563687.JPY","LU0742534661.SGD","FRDU","PBJ","LU0149721374.USD","EXI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655817336","title":"美國醫療保險和醫療補助服務中心：已確定2027財年專業護理機構預期支付系統費率調整方案，調整後，面向專業護理機構的總支付","url":"https://stock-news.laohu8.com/highlight/detail?id=2655817336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655817336?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 05:53","pubTimestamp":1785361994,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4154","IEHS","BK4566","RSPH","LU0417517546.SGD","LU0256863811.USD","LU0238689110.USD","LU0208291251.USD","FXH","BK4588","LU1093756325.SGD","LU1093756168.USD","IHF","SG9999014005.SGD","BK4533","LU1983260115.SGD","LU0266013472.USD","HUM","LU0348723411.USD","SG9999014013.SGD","LU0390134368.USD","UNHU","LU0320765489.SGD","LU0070302665.USD","LU0211331839.USD","BK4585","SG9999014021.USD","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":69,"code":"91000000","status":"200"}]}}